dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:22:00Z
dc.date.available2014-05-27T11:22:00Z
dc.date.created2014-05-27T11:22:00Z
dc.date.issued2006-10-05
dc.identifierRevista Brasileira de Otorrinolaringologia, v. 72, n. 3, p. 400-406, 2006.
dc.identifier0034-7299
dc.identifierhttp://hdl.handle.net/11449/69158
dc.identifier10.1590/S0034-72992006000300018
dc.identifierS0034-72992006000300018
dc.identifier2-s2.0-33749161876
dc.identifier2-s2.0-33749161876.pdf
dc.description.abstractAim: To evaluate the presence of preservatives, dyes, sweeteners and flavouring substances in 73 pharmaceutical preparations of 35 medicines for oral administration, according to drug labeling information about the excipients. Methods: 35 medications were selected, both over-the-counter and prescription durgs, marketed in Brazil. The sample included: analgesic/antipyretic, antimicrobial, mucoregulatory, cough and cold, decongestant, antihistamine, bronchodilator, corticosteroid, antiinflammatory and vitamin medications. We collected data on 73 preparations of these drugs, according to drug labeling information regarding preservatives, dyes, sweeteners and flavourings. Results: Methylparaben and propylparaben were the most common preservatives found (43% and 35.6% respectively). The most common sweeteners were: sucrose (sugar) (53.4%), sodium saccharin (38.3%) and sorbitol (36.9%). Twenty-one medicines (28,7%) contained two sweeteners. Colourless medicines predominated (43.8%), followed by those with sunset yellow dye (FD&C yellow no. 6) (15%). Five products (6.8%) contained more than one colour agent. Tartrazine (FD&C yellow no. 5) was present in seven preparations (9.5%). Fruit was the most common flavouring found (83%). Labelings of drugs which contained sugar frequently omitted its exact concentration (77%). Of the four labelings of medicines which contained aspartame, two did not warn patients regarding phenylketonuria. Conclusions: Omission and inacuracy of drug labeling information on pharmaceutical excipients may expose susceptible individuals to adverse reactions caused by preservatives and dyes. Complications of inadvertent intake of sugar-containing medicines by diabetics, or aspartame intake by patients with phenylketonuria may also occur.
dc.languagepor
dc.relationRevista Brasileira de Otorrinolaringologia
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectDrug labeling
dc.subjectFlavoring agents
dc.subjectParabens
dc.subjectPharmaceutic aids
dc.subjectPharmaceutical preservatives
dc.subjectTartrazine
dc.subjectamoxicillin
dc.subjectanalgesic agent
dc.subjectantihistaminic agent
dc.subjectantiinfective agent
dc.subjectantiinflammatory agent
dc.subjectantipyretic agent
dc.subjectaspartame
dc.subjectazithromycin
dc.subjectbronchodilating agent
dc.subjectcetirizine
dc.subjectcoloring agent
dc.subjectcorticosteroid
dc.subjectdecongestive agent
dc.subjectdrug additive
dc.subjectebastine
dc.subjectepinastine
dc.subjectibuprofen
dc.subjectloratadine
dc.subjectmethyl paraben
dc.subjectnimesulide
dc.subjectparacetamol
dc.subjectpreservative
dc.subjectpropyl paraben
dc.subjectsaccharin sodium
dc.subjectsorbitol
dc.subjectsucrose
dc.subjectsunset yellow
dc.subjecttartrazine
dc.subjectunindexed drug
dc.subjectvitamin
dc.subjectaccuracy
dc.subjectBrazil
dc.subjectchemical composition
dc.subjectconcentration (parameters)
dc.subjectconsumer health information
dc.subjectdrug formulary
dc.subjectdrug information
dc.subjectdrug labeling
dc.subjectphenylketonuria
dc.subjectColoring Agents
dc.subjectDrug Labeling
dc.subjectFlavoring Agents
dc.subjectHumans
dc.subjectPharmaceutic Aids
dc.subjectPharmaceutical Preparations
dc.subjectPreservatives, Pharmaceutical
dc.subjectSweetening Agents
dc.titleExcipientes de medicamentos e as informações da bula
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución